Welcome to PERFORM

In the next five years, PERFORM will develop a comprehensive management plan for febrile patients, capable of being implemented across different health-care systems in Europe, linking sophisticated new genomic and proteomic approaches to clinical phenotyping.

Why involving young people in research is important and how it changed the PERFORM study.

26 May 2020

The core outcome for the PERFORM study focusses on improving the diagnosis and treatment of febrile children. PERFORM researchers, Dr Emma Lim and Prof Marieke Emonts with their team, involved young people early on in the project by joining forces with The Young Person’s Advisory Group North England (YPAGne). We talk to Dr Emma Lim and members of the YPAGne community about the unexpected turns they and the young people experienced and outcomes.

New paper published: Detailed characterisation of a new inflammatory syndrome in children related to SARS_CoV-2 & comparison to KD & TSS

9 June 2020

After all the dedicated work investigating, the PERFORM consortia along with The PIMS-TS Study Group and EUCLIDS (PERFORM's predecessor study), have published their original investigations in the paper, Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

PERFORM and Erasmus+. Student exchange and enriching the PERFORM study.

10 July 2020

Interview with PhD student, Ilona van der Giessen and PERFORM researcher, Dr Marieke Emonts

The Erasmus Programme (EuRopean Community Action Scheme for the Mobility of University Students) is a European Union (EU) student exchange programme. As of 2014, this was redeveloped to Erasmus+ (opens in a new window); combining all the EU's current schemes for education, training, youth and sport.